lupus therapeutics Archives

Tag: lupus therapeutics

Lupus Research Alliance Showcases Research that will Shape Next Generation Treatments at ACR Convergence 2025

4 original posters to be presented on cell therapy, patient-reported outcomes, innovative recruitment strategies, and clinical trial retention in lupus 30+ presentations, posters, and discussions are currently supported by the Lupus Research Alliance or Lupus Therapeutics 45+ abstracts involve Lupus Clinical Investigators Network (LuCIN) or previously funded Lupus Research Alliance investigators – including 2 […] Read More

Community Spotlight: How Peer Educator Martha Chisholm is Living – And Advocating For – Life Beyond Lupus

What was once Martha Chisholm’s passion quickly became her greatest pain. Martha was in college, pursuing an education at Parsons School of Design in Manhattan – her dream. From painting to drawing, fashion to design, she was delving deeply into many creative outlets, drawing inspiration from the effervescent city surrounding her. That was until she […] Read More

Clinical Affiliate Lupus Therapeutics Names Grantee for Groundbreaking IDEAL Initiative

Could the future of lupus care be on your plate? Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance, launched a pioneering initiative – Investigate Dietary Approaches for Lupus (IDEAL) – exploring the connection between diet, gut health, and lupus care. That starts with funding a pilot study at the University of California, San Diego […] Read More

Lupus Research Alliance and Clinical Affiliate Lupus Therapeutics Selected as Inaugural Strategic Collaborators with Vie Ventures to Advance Innovative Autoimmune Therapies

The Lupus Research Alliance and clinical affiliate Lupus Therapeutics are proud to be selected as inaugural collaborators of the new life sciences investment firm, Vie Ventures. Vie Ventures is focused on bridging venture capital and disease philanthropy. The organization is concentrating on advancing late-stage, breakthrough therapies for autoimmune diseases and other immune system disorders where […] Read More

How Are the New Lupus Nephritis Guidelines Impacting Treatment?

Recognized as National Kidney Month, March is the ideal time to learn more about the 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Recently issued, the guidelines are designed to provide healthcare providers with up-to-date guidance on the care and treatment of adults and children with lupus […] Read More

LRA Forum for Discovery Showcases Cutting-Edge Lupus Research

The Lupus Research Alliance (LRA) hosted its highly anticipated annual scientific conference, Forum for Discovery (FFD), November 11-13 in New York City. A hallmark event for the lupus research community, FFD brings together LRA-funded investigators from across the globe to discuss the latest breakthroughs of their LRA-funded projects. Serving as a crucial platform for fostering […] Read More

Celebrating Native American Heritage Month: Meet Dr. Kent Kwoh, A Champion for Health Equity

During Native American Heritage Month, we celebrate a dedicated champion of health equity. As Chief of Rheumatology and Director of the Arthritis Center at University of Arizona, Dr. Kwoh is devoted to making sure the Indigenous people he treats receive the best possible care for their lupus. How? By listening, learning, and incorporating their perspectives […] Read More

Investigational Treatment Dapirolizumab Pegol Shows Positive Results in Phase 3 Clinical Trial

Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share positive topline results from the Phase 3 PHOENYCS GO study evaluating the investigational therapy dapirolizumab pegol in people living with moderate-to-severe systemic lupus. Results of the Phase 3 PHOENYCS GO study were reported by study sponsors UCB and Biogen. The […] Read More

Inspired by Patient Need, Dermatologist Specializes in Cutaneous Lupus

Dr. Victoria Werth decided to focus her career on researching and treating cutaneous (skin) lupus erythematosus because she saw a major need that she could help fill. Her story is especially appropriate this July during Ultraviolet Safety Month – as ultraviolet sun rays can trigger flares for people with cutaneous and/or systemic lupus. When Dr. […] Read More

Meet Unstoppable Advocate for Minority Health Christopher Reed

Determined to alleviate healthcare disparities for minorities, J. Christopher Reed, JD, urges our lupus community to use the power of National Minority Health Month to spotlight the issue this April. First diagnosed at 16, Christopher fought debilitating lupus symptoms to graduate college in eight years and then Tulane University Law School in three. Throughout college […] Read More

Lupus Peer-to-Peer Early Education Program Expands

Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly successful Patient Advocates for Lupus Studies (PALS) program with the introduction of a first-in-lupus “Trial Buddy” component made possible by a partnership with Bristol Myers Squibb. The Trial Buddy addition provides extra support to people with […] Read More

Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics

Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on a Phase 1 trial of the company novel NK cell-based therapy AlloNK® (also known as AB-101), in combination with anti-CD20 antibodies, for patients with active lupus nephritis – inflammation of the kidneys caused by lupus. AlloNK […] Read More